Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,097 recruiting studies in this area right now.
By phase
- Not applicable4,198
- Phase 2594
- Phase 1414
- Phase 3327
- Phase 4252
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer337
- Cervical Cancer224
- Endometrial Cancer209
- Bladder Cancer188
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases122
- Breast Cancer112
- Chronic Kidney Disease107
- Infertility91
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama152
- Texas120
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado84
- Illinois79
Recruiting studies6,097 total
- NCT06479811RecruitingPhase 1
Radioactive drug for advanced neuroendocrine and other cancers
This early-stage trial tests a new radioactive drug (called [212Pb]VMT-Alpha-NET) that targets a marker on certain cancer cells. It may help shrink or slow the growth of tumors that have spread or can't be removed, and it's being studied for several cancer types, including neuroendocrine tumors, small cell lung cancer, kidney cancer, and some head and neck cancers.
Bethesda, MarylandAges 18–120 - NCT05107674RecruitingPhase 1
Early drug study for advanced cancers that have limited options
This Phase 1 study tests NX-1607 in adults with advanced cancers that are hard to treat with standard care. It focuses on safety and early signs of how well the drug may work in specific cancer types.
Duarte, CaliforniaAges 18 years+ - NCT06302569RecruitingPhase 2
Pembrolizumab plus enfortumab vedotin for rare kidney cancers
This trial tests a combination of two drugs—pembrolizumab (an immunotherapy) and enfortumab vedotin (a targeted therapy)—for people with collecting duct carcinoma or renal medullary carcinoma, two rare types of kidney cancer that have spread. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
MilanAges 18 years+ - NCT06373913Recruiting
PCSK9's role in kidney damage in nephrotic syndrome
This study looks at how a protein called PCSK9 might affect kidney damage in people with nephrotic syndrome. It is for adults admitted to Kolding Hospital and aims to better understand the link between this protein and kidney problems.
KoldingAges 18 years+ - NCT06469736Recruiting
Comparing two methods for removing kidney stones
This study compares two ways to remove kidney stones: using a scope with a laser to break up stones, versus using the same scope plus a special gel to help remove the pieces. It aims to see if adding the gel makes the procedure more effective and safer.
Munich, BavariaAges 18 years+ - NCT06485323Recruiting
MRI vs CT for pelvic measurements in pregnancy
This trial tests whether an MRI can replace the usual CT scan to measure the size of your pelvis before a planned C-section. It aims to avoid radiation exposure during pregnancy.
BrusselsAges 18–99 - NCT06481995RecruitingPhase 4
Factor XIII for preventing heavy bleeding after childbirth
This study tests whether giving factor XIII, a natural protein that helps blood clot, can reduce excessive bleeding after vaginal delivery. It is for women who are at least 30 weeks pregnant with a single baby and who do not have certain medical conditions.
Geneva, Canton of GenevaAges 18 years+ - NCT06495554Recruiting
Danish vulva cancer recurrence study
This study looks at how vulva cancer returns (recurrence) over time. It aims to improve follow-up care for people who have had this type of cancer.
Aarhus NAges 18 years+ - NCT06493357Recruiting
Improving HIV testing and care for mothers and babies in Malawi
This study is testing a new way to find and treat HIV in pregnant women and new mothers in Malawi. It may help prevent passing HIV from mother to baby.
Lilongwe, Central RegionAges 16 years+ - NCT06488222RecruitingPhase 2
Chemotherapy for low-grade bladder cancer that comes back
This trial tests whether putting two chemotherapy drugs (gemcitabine and docetaxel) directly into the bladder can treat low-grade bladder cancer that is at intermediate risk. The goal is to see if this approach can help people avoid more invasive treatments.
Gainesville, FloridaAges 18 years+ - NCT06488781RecruitingPhase 2
Antibiotics before labor induction for first-time moms with obesity
This study tests whether giving a single antibiotic (azithromycin) before labor induction can help prevent complications in first-time mothers who have obesity. It aims to make delivery safer for you and your baby.
Oklahoma City, OklahomaAges 15–45 - NCT06492785Recruiting
Hyaluronic acid in embryo transfer for better success
This trial tests whether adding hyaluronic acid to the fluid used during embryo transfer helps more embryos implant, leading to a successful pregnancy. It's for people having a single embryo transfer with their own eggs.
Xi'an, ShaanxiAges Any age - NCT06483048RecruitingPhase 1
MUC1-targeted T cells for relapsed ovarian cancer
This trial tests a new treatment using your own immune cells, modified to target a protein called MUC1 on ovarian cancer cells. It is for people with ovarian cancer that has come back or is resistant to standard treatments.
Scottsdale, ArizonaAges 18 years+ - NCT06492070RecruitingPhase 2
Cooling therapy with or without cilostazol to prevent nerve damage from paclitaxel
This study tests whether cooling your hands and feet during chemotherapy, with or without the medicine cilostazol, can help prevent nerve damage (numbness, tingling, or pain) caused by the drug paclitaxel. It is for people with gynecologic cancers who are about to start or have just finished paclitaxel treatment.
Atlanta, GeorgiaAges 18 years+ - NCT06494878RecruitingPhase 3
Aspirin after childbirth to prevent blood clots
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
BrusselsAges 18 years+ - NCT06490146Recruiting
Menopause, hormones and blood vessel health
This study looks at how the change in hormones during menopause affects blood vessel and nerve health. It involves two visits to test how your body responds to certain changes, helping researchers understand women's heart health during this life stage.
Minneapolis, MinnesotaAges 45–55 - NCT06480695Recruiting
Exercise and Beetroot Supplement in Post-Menopausal Women
This study tests whether different exercise intensities combined with a beetroot-based nitrate supplement can improve blood vessel health in post-menopausal women who do not currently exercise regularly.
Charlottesville, VirginiaAges 45–75 - NCT06487546Recruiting
Ergothioneine supplement study for dialysis patients
This study tests whether giving a natural antioxidant called ergothioneine can help people with kidney failure who are on dialysis. It aims to see if it improves their health or well-being.
Palo Alto, CaliforniaAges 18 years+ - NCT06481631Recruiting
Building trust between mothers and doctors after high-risk pregnancy
This trial studies ways to build trust between new mothers and healthcare providers after a high-risk pregnancy. It focuses on helping mothers in five rural Mississippi counties get better postpartum care.
Jackson, MississippiAges 18–45 - NCT03627013RecruitingPhase 3
Compare two transplant fluid solutions for kidney, liver, pancreas
This Phase 3 study compares two types of transplant fluid (Custodiol-N vs Custodiol) to protect organs while they are stored before surgery. It may help by reducing damage to the kidney, liver, or pancreas during transplant preparation.
GrazAges 18 years+ - NCT05009082RecruitingPhase 3
Niraparib alone or with bevacizumab for advanced ovarian cancer
This trial studies whether niraparib works better when combined with bevacizumab after chemotherapy and surgery for advanced ovarian, fallopian tube, or peritoneal cancer. If you qualify, you may help researchers find a treatment plan that controls the cancer for longer.
AmbergAges 18 years+ - NCT05997407Recruiting
Managing stress through mindset for women with infertility
This study tests a mindset-based program to help reduce stress in women dealing with infertility. It is designed for new patients at two specific fertility clinics who have not yet had fertility treatment with a specialist.
Roanoke, VirginiaAges 18–42 - NCT06063122Recruiting
Device to help preterm babies tell speech sounds apart
This study tests a new device that plays special sounds to help preterm babies learn to tell different speech sounds apart. It is for babies born between 32 and 35 weeks of pregnancy to see if the device can improve their hearing and brain development.
Atlanta, GeorgiaAges 7 months–8 months - NCT06469281RecruitingPhase 1
A new immune cell therapy for recurring ovarian cancer
This early-phase trial tests a new immune cell therapy called 27T51, which targets a protein called MUC16 found on ovarian cancer cells. The study is for people with recurrent or treatment-resistant ovarian, primary peritoneal, or fallopian tube cancer to see if the therapy is safe and works when given alone or with other treatments.
Boston, MassachusettsAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,097 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,954 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.